Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had chest pain that feels like it is coming from around the heart or that resembles a heart attack.
- People who have had shortness of breath during activity or at rest for up to 3 months.
- People who have had shortness of breath during activity or at rest lasting between 3 months and 1 year.
- People who have had unexplained heart palpitations, irregular heart rhythms, or who have survived a sudden cardiac arrest.
- People who have had an unexplained episode where the heart suddenly could not pump enough blood (cardiogenic shock).
- People whose heart electrical test (ECG) showed new abnormalities, such as problems with the heart's electrical conduction or unusual wave patterns.
- People who have had elevated blood levels of proteins (troponin) that indicate possible heart muscle stress or damage.
- People whose heart is not pumping or moving normally in ways that cannot be explained by another condition.
- People whose heart MRI scan met specific criteria (called the Lake Louise criteria) suggesting heart inflammation.
- People who have provided their signed agreement to take part in the trial (informed consent).
Who may not be able to join:
- No exclusion criteria were listed in the information provided (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Domingo Pascual Figal, MD, HCUVA
Phone: 868885273
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
characterization of a large national cohort of patients with suspected myocarditis or inflammatory cardiomyopathy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.